Alexander Nyström Selected Research

Transforming Growth Factors (Transforming Growth Factor)

1/2019

Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander Nyström Research Topics

Disease

22	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 04/2024 - 01/2013
11	Fibrosis (Cirrhosis) 04/2024 - 09/2015
9	Neoplasms (Cancer) 01/2021 - 01/2008
7	Wounds and Injuries (Trauma) 08/2021 - 01/2016
5	Inflammation (Inflammations) 05/2020 - 09/2015
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2024 - 01/2016
4	Epidermolysis Bullosa 01/2022 - 01/2013
3	Skin Diseases (Skin Disease) 01/2021 - 01/2013
2	Carcinogenesis 11/2023 - 02/2016
2	Cicatrix (Scar) 01/2022 - 01/2021
2	Blister (Bulla) 01/2022 - 11/2014
2	Muscular Dystrophies (Muscular Dystrophy) 08/2006 - 09/2005
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023
1	Myocardial Infarction 01/2023
1	Atherosclerosis 01/2023
1	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Autoimmune Lymphoproliferative Syndrome 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Bullous Pemphigoid (Pemphigoid) 01/2022
1	Common Variable Immunodeficiency 01/2022
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2022
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 06/2019
1	Congenital Abnormalities (Deformity) 01/2019
1	Adenocarcinoma 01/2019
1	Foot Deformities (Foot Deformity) 01/2019
1	Disease Progression 01/2019
1	Hypertension (High Blood Pressure) 11/2018
1	Skin Manifestations 10/2018
1	Wound Infection (Wound Infections) 01/2018
1	Papilloma (Papillomatosis) 02/2016
1	Male Infertility (Male Sterility) 09/2005

Drug/Important Bio-Agent (IBA)

18	CollagenIBA 11/2023 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
5	Collagen Type VIIIBA 11/2023 - 11/2014
4	IntegrinsIBA 01/2021 - 08/2006
3	Antisense OligonucleotidesIBA 01/2024 - 10/2016
3	ProteomeIBA 10/2021 - 01/2018
2	EnzymesIBA 01/2023 - 11/2018
2	Losartan (Cozaar)FDA LinkGeneric 01/2023 - 09/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 01/2021
2	DecorinIBA 01/2019 - 05/2009
2	Collagen Type XVIIIBA 02/2016 - 01/2016
2	Laminin (Merosin)IBA 08/2006 - 09/2005
1	Fibronectins (Fibronectin)IBA 04/2024
1	NucleotidesIBA 01/2024
1	RNA Precursors (Precursor, mRNA)IBA 01/2024
1	trametinibIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	AutoantibodiesIBA 01/2022
1	AntigensIBA 01/2022
1	Extracellular Matrix ProteinsIBA 01/2022
1	Tiopronin (Thiola)FDA Link 08/2021
1	carbomerIBA 01/2021
1	Thrombospondin 1IBA 01/2021
1	Cell Surface ReceptorsIBA 11/2020
1	AntibodiesIBA 11/2019
1	Protein AggregatesIBA 06/2019
1	Keratin-5 (Keratin 5)IBA 06/2019
1	4-phenylbutyric acid (Buphenyl)FDA Link 06/2019
1	Keratins (Keratin)IBA 06/2019
1	DisintegrinsIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2019
1	LigandsIBA 11/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Complement System Proteins (Complement)IBA 12/2017
1	RNA (Ribonucleic Acid)IBA 03/2016
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 02/2016
1	CarcinogensIBA 02/2016
1	Sirolimus (Rapamycin)FDA Link 01/2016
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2009
1	AgrinIBA 05/2009
1	Collagen Type XVIII (Type XVIII Collagen)IBA 05/2009
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 05/2009
1	Proteoglycans (Proteoglycan)IBA 05/2009
1	perlecanIBA 05/2009
1	Small Leucine-Rich ProteoglycansIBA 05/2009
1	ErbB Receptors (EGF Receptor)IBA 05/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2009
1	Integrin alpha2beta1IBA 01/2008
1	laminin alpha 2IBA 09/2005

Therapy/Procedure

11	Therapeutics 11/2023 - 01/2013
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2019 - 11/2014
1	Injections 01/2022
1	Intradermal Injections 11/2014